Peel Hunt Kept Victrex PLC (LON:VCT) As a “Add”; They Now Have a PT Of GBX 2850.00

May 17, 2018 - By James Guidry

Victrex PLC (LON:VCT) Rating Reaffirmed

They currently have a GBX 2850.00 target price on Victrex PLC (LON:VCT). The target price by Peel Hunt would suggest a potential upside of 2.26 % from the company’s current price. This has been shown in an analyst report on Thursday morning.

Victrex plc (LON:VCT) Ratings Coverage

Among 9 analysts covering Victrex PLC (LON:VCT), 4 have Buy rating, 1 Sell and 4 Hold. Therefore 44% are positive. Victrex PLC has GBX 2850 highest and GBX 1380 lowest target. GBX 2411.67’s average target is -13.81% below currents GBX 2798 stock price. Victrex PLC had 26 analyst reports since November 28, 2017 according to SRatingsIntel. The firm has “Underperform” rating given on Thursday, April 5 by BNP Paribas. On Friday, December 8 the stock rating was maintained by Liberum Capital with “Buy”. The rating was maintained by Liberum Capital on Tuesday, January 30 with “Buy”. The firm has “Hold” rating by Peel Hunt given on Friday, February 9. The firm has “Buy” rating given on Tuesday, April 3 by Liberum Capital. The firm has “Buy” rating given on Monday, February 5 by Liberum Capital. The company was maintained on Friday, February 9 by Liberum Capital. As per Wednesday, December 6, the company rating was maintained by JP Morgan. On Thursday, May 17 the stock rating was maintained by Peel Hunt with “Add”. The rating was maintained by Berenberg with “Buy” on Friday, February 23.

The stock increased 2.57% or GBX 70 during the last trading session, reaching GBX 2798. About 139,974 shares traded. Victrex plc (LON:VCT) has 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Victrex plc, through its subsidiaries, makes and sells polymers worldwide. The company has market cap of 2.40 billion GBP. It operates through two divisions, Victrex Polymer Solutions and Invibio Biomaterial Solutions. It has a 24.08 P/E ratio. The firm offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.